Volume | 352,034 |
|
|||||
News | - | ||||||
Day High | 15.01 | Low High |
|||||
Day Low | 14.635 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Bausch plus Lomb Corporation | BLCO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
14.67 | 14.635 | 15.01 | 14.85 | 14.64 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,551 | 352,034 | $ 14.89 | $ 5,240,453 | - | 13.62 - 21.95 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 24,607 | $ 14.85 | USD |
Bausch plus Lomb Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.13B | 350.99M | - | 4.15B | -260M | -0.74 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bausch plus Lomb News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BLCO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 14.30 | 15.01 | 13.89 | 14.38 | 444,780 | 0.55 | 3.85% |
1 Month | 16.61 | 17.525 | 13.80 | 15.21 | 557,641 | -1.76 | -10.60% |
3 Months | 14.50 | 17.695 | 13.62 | 15.53 | 473,501 | 0.35 | 2.41% |
6 Months | 16.78 | 17.695 | 13.62 | 15.57 | 513,399 | -1.93 | -11.50% |
1 Year | 17.17 | 21.95 | 13.62 | 16.99 | 486,322 | -2.32 | -13.51% |
3 Years | 18.50 | 21.95 | 12.20 | 16.45 | 619,845 | -3.65 | -19.73% |
5 Years | 18.50 | 21.95 | 12.20 | 16.45 | 619,845 | -3.65 | -19.73% |
Bausch plus Lomb Description
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. |